Kumar Anand, Sayak Khawas, Apurva Singh, Puja kumari, Neha Nupur and Neelima Sharma
Background: Natural products and their structural analogues have historically played a crucial role in pharmacotherapy, especially in the treatment of cancer and infectious diseases. However, various challenges including screening, isolation, characterization and effectiveness contributed to a decline in natural product research within the pharmaceutical industry.
Purpose: This review explores the enduring use of natural compounds in folk medicine with special focus on drug discovery inspired by multifaceted molecular roles of small molecules from natural sources. The article also aims to elucidate how modern modifications of these compounds can lead to the development of innovative molecules with enhanced pharmacological potential & can have good pharmaceutics profile.
Methods: To accomplish these objectives, literature has been surveyed from PUBMED, MEDLINE, EMBASE etc. like search engines, for pinpointing detailed technological developments that empower natural product-based drug discovery. Various case studies are incorporated in terms of folklore usage, in process drug discoveries and small molecules scientifically founded with signalling pathway bio stimulation.
Conclusions: The journey of natural products from nature to clinic is very complex and time taking. In this pipeline, if attention can be drawn to some major aspects, it will lead to a paradigm shift in drug discovery processes. This can be witnessed by folklore usage of natural products and up laddering multifaceted concepts of small and lead molecule
Aghababaei, F., & Hadidi, M. (2023). Recent Advances in Potential Health Benefits of Quercetin. Pharmaceuticals (Basel, Switzerland), 16(7), 1020. https://doi.org/10.3390/ph16071020
Albarano, L., Esposito, R., Ruocco, N., & Costantini, M. (2020). Genome Mining as New Challenge in Natural Products Discovery. Marine drugs, 18(4), 199. https://doi.org/10.3390/md18040199
Aminov R. I. (2010). A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in microbiology, 1, 134. https://doi.org/10.3389/fmicb.2010.00134
Anand David, A. V., Arulmoli, R., & Parasuraman, S. (2016). Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacognosy reviews, 10(20), 84–89. https://doi.org/10.4103/0973-7847.194044
Aswathy, M., Vijayan, A., Daimary, U. D., Girisa, S., Radhakrishnan, K. V., & Kunnumakkara, A. B. (2022). Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives. Journal of biochemical and molecular toxicology, 36(12), e23206. https://doi.org/10.1002/jbt.23206
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E. M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., Rollinger, J. M., Schuster, D., Breuss, J. M., Bochkov, V., Mihovilovic, M. D., Kopp, B., Bauer, R., Dirsch, V. M., & Stuppner, H. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnology advances, 33(8), 1582–1614.
https://doi.org/10.1016/j.biotechadv.2015.08.001
Baltz R. H. (2019). Natural product drug discovery in the genomic era: realities, conjectures, misconceptions, and opportunities. Journal of industrial microbiology & biotechnology, 46(3-4), 281–299. https://doi.org/10.1007/s10295-018-2115-4
Bauer, A., & Brönstrup, M. (2014). Industrial natural product chemistry for drug discovery and development. Natural product reports, 31(1), 35–60. https://doi.org/10.1039/c3np70058e
Bentley R. (2009). Different roads to discovery; Prontosil (hence sulfa drugs) and penicillin (hence beta-lactams). Journal of industrial microbiology & biotechnology, 36(6), 775–786. https://doi.org/10.1007/s10295-009-0553-8
Bhullar, K. S., & Hubbard, B. P. (2015). Lifespan and healthspan extension by resveratrol. Biochimica et biophysica acta, 1852(6), 1209–1218. https://doi.org/10.1016/j.bbadis.2015.01.012
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014). Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor perspectives in biology, 6(1), a009191. https://doi.org/10.1101/cshperspect.a009191
Cao, X., Wang, Y., Zhang, W., Zhong, X., Gunes, E. G., Dang, J., Wang, J., Epstein, A. L., Querfeld, C., Sun, Z., Rosen, S. T., & Feng, M. (2022). Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression. Blood, 139(22), 3290–3302. https://doi.org/10.1182/blood.2021013901
Cappelletti, S., Piacentino, D., Sani, G., & Aromatario, M. (2015). Caffeine: cognitive and physical performance enhancer or psychoactive drug?. Current neuropharmacology, 13(1), 71–88. https://doi.org/10.2174/1570159X13666141210215655
Carvalho, M. R., Truckenmuller, R., Reis, R. L., & Oliveira, J. M. (2020). Biomaterials and Microfluidics for Drug Discovery and Development. Advances in experimental medicine and biology, 1230, 121–135. https://doi.org/10.1007/978-3-030-36588-2_8
Chamorro-Cevallos, G., Mojica-Villegas, M. A., García-Martínez, Y., Pérez-Gutiérrez, S., Madrigal-Santillán, E., Vargas-Mendoza, N., Morales-González, J. A., & Cristóbal-Luna, J. M. (2022). A Complete Review of Mexican Plants with Teratogenic Effects. Plants (Basel, Switzerland), 11(13), 1675. https://doi.org/10.3390/plants11131675
Chen, Y., & Kirchmair, J. (2020). Cheminformatics in Natural Product-based Drug Discovery. Molecular informatics, 39(12), e2000171. https://doi.org/10.1002/minf.202000171
Cichewicz, R. H., & Kouzi, S. A. (2004). Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Medicinal research reviews, 24(1), 90–114. https://doi.org/10.1002/med.10053
Clapp, N., Amour, A., Rowan, W. C., & Candarlioglu, P. L. (2021). Organ-on-chip applications in drug discovery: an end user perspective. Biochemical Society transactions, 49(4), 1881–1890. https://doi.org/10.1042/BST20210840
Cragg G. M. (1998). Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development. Medicinal research reviews, 18(5), 315–331. https://doi.org/10.1002/(sici)1098-1128(199809)18:5<315::aid-med3>3.0.co;2-w
Cragg, G. M., & Newman, D. J. (2013). Natural products: a continuing source of novel drug leads. Biochimica et biophysica acta, 1830(6), 3670–3695. https://doi.org/10.1016/j.bbagen.2013.02.008
Desborough, M. J. R., & Keeling, D. M. (2017). The aspirin story – from willow to wonder drug. British journal of haematology, 177(5), 674–683. https://doi.org/10.1111/bjh.14520
Dias, D. A., Urban, S., & Roessner, U. (2012). A historical overview of natural products in drug discovery. Metabolites, 2(2), 303–336. https://doi.org/10.3390/metabo2020303
Dong, H., & Ming, D. (2023). A Comprehensive Self-Resistance Gene Database for Natural-Product Discovery with an Application to Marine Bacterial Genome Mining. International journal of molecular sciences, 24(15), 12446. https://doi.org/10.3390/ijms241512446
Dzobo K. (2022). The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. Comprehensive Pharmacology, 408–422. https://doi.org/10.1016/B978-0-12-820472-6.00041-4
Ebob, O. T., Babiaka, S. B., & Ntie-Kang, F. (2021). Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2. Natural products and bioprospecting, 11(6), 611–628. https://doi.org/10.1007/s13659-021-00317-w
El-Saber Batiha, G., Magdy Beshbishy, A., G Wasef, L., Elewa, Y. H. A., A Al-Sagan, A., Abd El-Hack, M. E., Taha, A. E., M Abd-Elhakim, Y., & Prasad Devkota, H. (2020). Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review. Nutrients, 12(3), 872. https://doi.org/10.3390/nu12030872
Erenler, R., Meral, B., Sen, O., Elmastas, M., Aydin, A., Eminagaoglu, O., & Topcu, G. (2017). Bioassay-guided isolation, identification of compounds from Origanum rotundifolium and investigation of their antiproliferative and antioxidant activities. Pharmaceutical biology, 55(1), 1646–1653. https://doi.org/10.1080/13880209.2017.1310906
Fattori, D., Squarcia, A., & Bartoli, S. (2008). Fragment-based approach to drug lead discovery: overview and advances in various techniques. Drugs in R&D, 9(4), 217–227. https://doi.org/10.2165/00126839-200809040-00002
Foa, R., Norton, L., & Seidman, A. D. (1994). Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. International journal of clinical & laboratory research, 24(1), 6–14. https://doi.org/10.1007/BF02592403
Fu, Y., Luo, J., Qin, J., & Yang, M. (2019). Screening techniques for the identification of bioactive compounds in natural products. Journal of pharmaceutical and biomedical analysis, 168, 189–200. https://doi.org/10.1016/j.jpba.2019.02.027
Gajula, S. N. R., Nadimpalli, N., & Sonti, R. (2021). Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug metabolism reviews, 53(3), 459–477. https://doi.org/10.1080/03602532.2021.1970178
Gallego-Jara, J., Lozano-Terol, G., Sola-Martínez, R. A., Cánovas-Díaz, M., & de Diego Puente, T. (2020). A Compressive Review about Taxol®: History and Future Challenges. Molecules (Basel, Switzerland), 25(24), 5986. https://doi.org/10.3390/molecules25245986
Gazák, R., Walterová, D., & Kren, V. (2007). Silybin and silymarin–new and emerging applications in medicine. Current medicinal chemistry, 14(3), 315–338. https://doi.org/10.2174/092986707779941159
Geng, F. H., Li, G. H., Zhang, X., Zhang, P., Dong, M. Q., Zhao, Z. J., Zhang, Y., Dong, L., & Gao, F. (2016). Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats. British journal of pharmacology, 173(10), 1569–1579. https://doi.org/10.1111/bph.13466
Grabowski, K., Baringhaus, K. H., & Schneider, G. (2008). Scaffold diversity of natural products: inspiration for combinatorial library design. Natural product reports, 25(5), 892–904. https://doi.org/10.1039/b715668p
Graham-Brown, R. A. C., & Healsmith, M. F. (2018). From folklore to pharmacy: Putting plants into practice. Clinics in dermatology, 36(3), 282–288. https://doi.org/10.1016/j.clindermatol.2018.03.002
Guido, R. V., Oliva, G., & Andricopulo, A. D. (2011). Modern drug discovery technologies: opportunities and challenges in lead discovery. Combinatorial chemistry & high throughput screening, 14(10), 830–839. https://doi.org/10.2174/138620711797537067
Guo Z. (2016). Artemisinin anti-malarial drugs in China. Acta pharmaceutica Sinica. B, 6(2), 115–124. https://doi.org/10.1016/j.apsb.2016.01.008
Hannan, M. A., Rahman, M. A., Sohag, A. A. M., Uddin, M. J., Dash, R., Sikder, M. H., Rahman, M. S., Timalsina, B., Munni, Y. A., Sarker, P. P., Alam, M., Mohibbullah, M., Haque, M. N., Jahan, I., Hossain, M. T., Afrin, T., Rahman, M. M., Tahjib-Ul-Arif, M., Mitra, S., Oktaviani, D. F., … Kim, B. (2021). Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients, 13(6), 1784. https://doi.org/10.3390/nu13061784
Hefti F. F. (2008). Requirements for a lead compound to become a clinical candidate. BMC neuroscience, 9 Suppl 3(Suppl 3), S7. https://doi.org/10.1186/1471-2202-9-S3-S7
Hon, K. L., & Lee, V. W. (2017). Challenges for drug discovery and development in China. Expert opinion on drug discovery, 12(1), 105–113. https://doi.org/10.1080/17460441.2017.1257115
Honório, K. M., Moda, T. L., & Andricopulo, A. D. (2013). Pharmacokinetic properties and in silico ADME modeling in drug discovery. Medicinal chemistry (Shariqah (United Arab Emirates)), 9(2), 163–176. https://doi.org/10.2174/1573406411309020002
Hornburg, C. C., Britt, J. R., Evans, J. R., Akee, R. K., Whitt, J. A., Trinh, S. K., Harris, M. J., Thompson, J. R., Ewing, T. L., Shipley, S. M., Grothaus, P. G., Newman, D. J., Schneider, J. P., Grkovic, T., & O’Keefe, B. R. (2018). NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening. ACS chemical biology, 13(9), 2484–2497. https://doi.org/10.1021/acschembio.8b00389
Hu, Y., Guo, N., Yang, T., Yan, J., Wang, W., & Li, X. (2022). The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer. Oxidative medicine and cellular longevity, 2022, 1458143. https://doi.org/10.1155/2022/1458143
Iao, Z., Morris-Natschke, S. L., & Lee, K. H. (2016). Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Medicinal research reviews, 36(1), 32–91. https://doi.org/10.1002/med.21377
Kane, R. C., Farrell, A. T., Saber, H., Tang, S., Williams, G., Jee, J. M., Liang, C., Booth, B., Chidambaram, N., Morse, D., Sridhara, R., Garvey, P., Justice, R., & Pazdur, R. (2006). Sorafenib for the treatment of advanced renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 12(24), 7271–7278. https://doi.org/10.1158/1078-0432.CCR-06-1249
Katz, L., & Baltz, R. H. (2016). Natural product discovery: past, present, and future. Journal of industrial microbiology & biotechnology, 43(2-3), 155–176. https://doi.org/10.1007/s10295-015-1723-5
Khalaf R. A. (2016). Exploring Natural Products as a Source for Antidiabetic Lead Compounds and Possible Lead Optimization. Current topics in medicinal chemistry, 16(23), 2549–2561. https://doi.org/10.2174/1568026616666160414123602
Khan, U. M., Sevindik, M., Zarrabi, A., Nami, M., Ozdemir, B., Kaplan, D. N., Selamoglu, Z., Hasan, M., Kumar, M., Alshehri, M. M., & Sharifi-Rad, J. (2021). Lycopene: Food Sources, Biological Activities, and Human Health Benefits. Oxidative medicine and cellular longevity, 2021, 2713511. https://doi.org/10.1155/2021/2713511
Kidd, S. L., Osberger, T. J., Mateu, N., Sore, H. F., & Spring, D. R. (2018). Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections. Frontiers in chemistry, 6, 460. https://doi.org/10.3389/fchem.2018.00460
Kim, J. H., Lee, N., Hwang, S., Kim, W., Lee, Y., Cho, S., Palsson, B. O., & Cho, B. K. (2021). Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture. Journal of industrial microbiology & biotechnology, 48(3-4), kuaa001. https://doi.org/10.1093/jimb/kuaa001
Klebe G. (2006). Virtual ligand screening: strategies, perspectives and limitations. Drug discovery today, 11(13-14), 580–594.
https://doi.org/10.1016/j.drudis.2006.05.012
Koeberle, A., & Werz, O. (2014). Multi-target approach for natural products in inflammation. Drug discovery today, 19(12), 1871–1882. https://doi.org/10.1016/j.drudis.2014.08.006
Kohler, D. R., & Goldspiel, B. R. (1994). Paclitaxel (taxol). Pharmacotherapy, 14(1), 3–34. https://doi.org/10.1002/j.1875-9114.1994.tb02785.x
Kong, L. Y., & Tan, R. X. (2015). Artemisinin, a miracle of traditional Chinese medicine. Natural product reports, 32(12), 1617–1621. https://doi.org/10.1039/c5np00133a
Lam, R., Gondin, A. B., Canals, M., Kellam, B., Briddon, S. J., Graham, B., & Scammells, P. J. (2018). Fluorescently Labeled Morphine Derivatives for Bioimaging Studies. Journal of medicinal chemistry, 61(3), 1316–1329. https://doi.org/10.1021/acs.jmedchem.7b01811
Laux, A., Muller, A. H., Miehe, M., Dirrig-Grosch, S., Deloulme, J. C., Delalande, F., Stuber, D., Sage, D., Van Dorsselaer, A., Poisbeau, P., Aunis, D., & Goumon, Y. (2011). Mapping of endogenous morphine-like compounds in the adult mouse brain: Evidence of their localization in astrocytes and GABAergic cells. The Journal of comparative neurology, 519(12), 2390–2416. https://doi.org/10.1002/cne.22633
Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K. V. M., Schmitner, N., Kimmel, R. A., Romanov, R. A., Sturtzel, C., Lardeau, C. H., Klughammer, J., Farlik, M., Sdelci, S., Vieira, A., Avolio, F., Briand, F., Baburin, I., Májek, P., … Kubicek, S. (2017). Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity. Cell, 168(1-2), 86–100.e15. https://doi.org/10.1016/j.cell.2016.11.010
Li, Q., & Kang, C. (2020). Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery. International journal of molecular sciences, 21(15), 5262. https://doi.org/10.3390/ijms21155262
Ligon B. L. (2004). Penicillin: its discovery and early development. Seminars in pediatric infectious diseases, 15(1), 52–57 https://doi.org/10.1053/j.spid.2004.02.001
Lima, L. M., Silva, B. N. M. D., Barbosa, G., & Barreiro, E. J. (2020). β-lactam antibiotics: An overview from a medicinal chemistry perspective. European journal of medicinal chemistry, 208, 112829. https://doi.org/10.1016/j.ejmech.2020.112829
Lin, C. R., Tsai, S. H. L., Wang, C., Lee, C. L., Hung, S. W., Ting, Y. T., & Hung, Y. C. (2023). Willow Bark (Salix spp.) Used for Pain Relief in Arthritis: A Meta-Analysis of Randomized Controlled Trials. Life (Basel, Switzerland), 13(10), 2058. https://doi.org/10.3390/life13102058
Lin, Z., Zhang, Y., Zhang, Y., Shen, H., Hu, L., Jiang, H., & Shen, X. (2008). Oleanolic acid derivative NPLC441 potently stimulates glucose transport in 3T3-L1 adipocytes via a multi-target mechanism. Biochemical pharmacology, 76(10), 1251–1262. https://doi.org/10.1016/j.bcp.2008.08.016
Liu, R., Dong, H. F., & Jiang, M. S. (2012). Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control. Parasitology research, 110(5), 2071–2074. https://doi.org/10.1007/s00436-011-2707-7
Liu, R., Li, X., & Lam, K. S. (2017). Combinatorial chemistry in drug discovery. Current opinion in chemical biology, 38, 117–126. https://doi.org/10.1016/j.cbpa.2017.03.017
Liu, Y., Wang, Z. Y., Xu, W. J., Zhang, C. J., & Dong, L. (2019). Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 44(17), 3637–3644. https://doi.org/10.19540/j.cnki.cjcmm.20190629.310
Ludy, M. J., Moore, G. E., & Mattes, R. D. (2012). The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans. Chemical senses, 37(2), 103–121. https://doi.org/10.1093/chemse/bjr100
Luo, Y., Cobb, R. E., & Zhao, H. (2014). Recent advances in natural product discovery. Current opinion in biotechnology, 30, 230–237. https://doi.org/10.1016/j.copbio.2014.09.002
Ma, S., Wang, X., Lai, F., & Lou, C. (2020). The beneficial pharmacological effects and potential mechanisms of picroside II: Evidence of its benefits from in vitro and in vivo. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 130, 110421. https://doi.org/10.1016/j.biopha.2020.110421
Malve H. (2016). Exploring the ocean for new drug developments: Marine pharmacology. Journal of pharmacy & bioallied sciences, 8(2), 83–91. https://doi.org/10.4103/0975-7406.171700
McLellan, T. M., Caldwell, J. A., & Lieberman, H. R. (2016). A review of caffeine’s effects on cognitive, physical and occupational performance. Neuroscience and biobehavioral reviews, 71, 294–312. https://doi.org/10.1016/j.neubiorev.2016.09.001
Meissner, F., Geddes-McAlister, J., Mann, M., & Bantscheff, M. (2022). The emerging role of mass spectrometry-based proteomics in drug discovery. Nature reviews. Drug discovery, 21(9), 637–654. https://doi.org/10.1038/s41573-022-00409-3
Mishra, B. B., & Tiwari, V. K. (2011). Natural products: an evolving role in future drug discovery. European journal of medicinal chemistry, 46(10), 4769–4807. https://doi.org/10.1016/j.ejmech.2011.07.057
Molinski T. F. (2014). All natural: the renaissance of natural products chemistry. Organic letters, 16(15), 3849–3855. https://doi.org/10.1021/ol501917g
Mukherjee, R., Kumar, V., Srivastava, S. K., Agarwal, S. K., & Burman, A. C. (2006). Betulinic acid derivatives as anticancer agents: structure activity relationship. Anti-cancer agents in medicinal chemistry, 6(3), 271–279. https://doi.org/10.2174/187152006776930846
Musial, C., Kuban-Jankowska, A., & Gorska-Ponikowska, M. (2020). Beneficial Properties of Green Tea Catechins. International journal of molecular sciences, 21(5), 1744. https://doi.org/10.3390/ijms21051744
Najmi, A., Javed, S. A., Al Bratty, M., & Alhazmi, H. A. (2022). Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents. Molecules (Basel, Switzerland), 27(2), 349. https://doi.org/10.3390/molecules27020349
Nehlig, A., Daval, J. L., & Debry, G. (1992). Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain research. Brain research reviews, 17(2), 139–170. https://doi.org/10.1016/0165-0173(92)90012-b
Newman, D. J., & Cragg, G. M. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of natural products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
Oboh, M., Govender, L., Siwela, M., & Mkhwanazi, B. N. (2021). Anti-Diabetic Potential of Plant-Based Pentacyclic Triterpene Derivatives: Progress Made to Improve Efficacy and Bioavailability. Molecules (Basel, Switzerland), 26(23), 7243. https://doi.org/10.3390/molecules26237243
Ortholand, J. Y., & Ganesan, A. (2004). Natural products and combinatorial chemistry: back to the future. Current opinion in chemical biology, 8(3), 271–280. https://doi.org/10.1016/j.cbpa.2004.04.011
Patocka, J., Nepovimova, E., Wu, W., & Kuca, K. (2020). Digoxin: Pharmacology and toxicology-A review. Environmental toxicology and pharmacology, 79, 103400. https://doi.org/10.1016/j.etap.2020.103400
Patridge, E., Gareiss, P., Kinch, M. S., & Hoyer, D. (2016). An analysis of FDA-approved drugs: natural products and their derivatives. Drug discovery today, 21(2), 204–207. https://doi.org/10.1016/j.drudis.2015.01.009
Pirintsos, S., Panagiotopoulos, A., Bariotakis, M., Daskalakis, V., Lionis, C., Sourvinos, G., Karakasiliotis, I., Kampa, M., & Castanas, E. (2022). From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples. Molecules (Basel, Switzerland), 27(13), 4060. https://doi.org/10.3390/molecules27134060
Pleszczyńska, M., Wiater, A., Siwulski, M., Lemieszek, M. K., Kunaszewska, J., Kaczor, J., Rzeski, W., Janusz, G., & Szczodrak, J. (2016). Cultivation and utility of Piptoporus betulinus fruiting bodies as a source of anticancer agents. World journal of microbiology & biotechnology, 32(9), 151. https://doi.org/10.1007/s11274-016-2114-4
Prescott, T. A. K., Hill, R., Mas-Claret, E., Gaya, E., & Burns, E. (2023). Fungal Drug Discovery for Chronic Disease: History, New Discoveries and New Approaches. Biomolecules, 13(6), 986. https://doi.org/10.3390/biom13060986
Rakheja, I., Ansari, A. H., Ray, A., Chandra Joshi, D., & Maiti, S. (2022). Small molecule quercetin binds MALAT1 triplex and modulates its cellular function. Molecular therapy. Nucleic acids, 30, 241–256. https://doi.org/10.1016/j.omtn.2022.09.016
Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017). Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases. CNS drugs, 31(12), 1029–1041. https://doi.org/10.1007/s40263-017-0474-4
Ren, M., Jiang, S., Wang, Y., Pan, X., Pan, F., & Wei, X. (2023). Discovery and excavation of lichen bioactive natural products. Frontiers in microbiology, 14, 1177123. https://doi.org/10.3389/fmicb.2023.1177123
Saneja, A., Arora, D., Kumar, R., Dubey, R. D., Panda, A. K., & Gupta, P. N. (2018). Therapeutic applications of betulinic acid nanoformulations. Annals of the New York Academy of Sciences, 1421(1), 5–18. https://doi.org/10.1111/nyas.13570
Sarkar, C., Quispe, C., Jamaddar, S., Hossain, R., Ray, P., Mondal, M., Abdulwanis Mohamed, Z., Sani Jaafaru, M., Salehi, B., Islam, M. T., Faizal Abdull Razis, A., Martorell, M., Pastene-Navarrete, E., & Sharifi-Rad, J. (2020). Therapeutic promises of ginkgolide A: A literature-based review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 132, 110908. https://doi.org/10.1016/j.biopha.2020.110908
Seib, K. L., Dougan, G., & Rappuoli, R. (2009). The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS genetics, 5(10), e1000612. https://doi.org/10.1371/journal.pgen.1000612
Shah, K. K., Kogut, S., & Slitt, A. (2021). Challenges in Evaluating Safety and Efficacy in Drug Development for Rare Diseases: A Review for Pharmacists. Journal of pharmacy practice, 34(3), 472–479. https://doi.org/10.1177/0897190020930972
Sukmarini L. (2021). Recent Advances in Discovery of Lead Structures from Microbial Natural Products: Genomics- and Metabolomics-Guided Acceleration. Molecules (Basel, Switzerland), 26(9), 2542. https://doi.org/10.3390/molecules26092542
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022). Why 90% of clinical drug development fails and how to improve it?. Acta pharmaceutica Sinica. B, 12(7), 3049–3062. https://doi.org/10.1016/j.apsb.2022.02.002
Szymański, P., Markowicz, M., & Mikiciuk-Olasik, E. (2012). Adaptation of high-throughput screening in drug discovery-toxicological screening tests. International journal of molecular sciences, 13(1), 427–452. https://doi.org/10.3390/ijms13010427
Taylor, D. M., & Werneke, U. (2018). Ethnopharmacology†. Nordic journal of psychiatry, 72(sup1), S30–S32. https://doi.org/10.1080/08039488.2018.1525636
Teixeira S. (2002). Bioflavonoids: proanthocyanidins and quercetin and their potential roles in treating musculoskeletal conditions. The Journal of orthopaedic and sports physical therapy, 32(7), 357–363. https://doi.org/10.2519/jospt.2002.32.7.357
Tuli, H. S., Mistry, H., Kaur, G., Aggarwal, D., Garg, V. K., Mittal, S., Yerer, M. B., Sak, K., & Khan, M. A. (2022). Gallic Acid: A Dietary Polyphenol that Exhibits Anti-neoplastic Activities by Modulating Multiple Oncogenic Targets. Anti-cancer agents in medicinal chemistry, 22(3), 499–514. https://doi.org/10.2174/1871520621666211119085834
van Breemen, R. B., Muchiri, R. N., Bates, T. A., Weinstein, J. B., Leier, H. C., Farley, S., & Tafesse, F. G. (2022). Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. Journal of natural products, 85(1), 176–184. https://doi.org/10.1021/acs.jnatprod.1c00946\
Van der Walt, E. M., Milczek, E. M., Malan, S. F., Edmondson, D. E., Castagnoli, N., Jr, Bergh, J. J., & Petzer, J. P. (2009). Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorganic & medicinal chemistry letters, 19(9), 2509–2513. https://doi.org/10.1016/j.bmcl.2009.03.030
Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017). The metabolism of berberine and its contribution to the pharmacological effects. Drug metabolism reviews, 49(2), 139–157. https://doi.org/10.1080/03602532.2017.1306544
Wiley, D. S., Redfield, S. E., & Zon, L. I. (2017). Chemical screening in zebrafish for novel biological and therapeutic discovery. Methods in cell biology, 138, 651–679. https://doi.org/10.1016/bs.mcb.2016.10.004
Wishart D. S. (2016). Emerging applications of metabolomics in drug discovery and precision medicine. Nature reviews. Drug discovery, 15(7), 473–484. https://doi.org/10.1038/nrd.2016.32
Xu, Y., Liu, J., Wu, Y., Guo, Q., Sun, H., & Chen, G. (2015). Natural products against hematological malignancies and identification of their targets. Science China. Life sciences, 58(12), 1191–1201. https://doi.org/10.1007/s11427-015-4922-4
Yang, C. H., & Horwitz, S. B. (2017). Taxol®: The First Microtubule Stabilizing Agent. International journal of molecular sciences, 18(8), 1733. https://doi.org/10.3390/ijms18081733
Yuan, H., Ma, Q., Ye, L., & Piao, G. (2016). The Traditional Medicine and Modern Medicine from Natural Products. Molecules (Basel, Switzerland), 21(5), 559. https://doi.org/10.3390/molecules21050559
Zhang, M. M., Qiao, Y., Ang, E. L., & Zhao, H. (2017). Using natural products for drug discovery: the impact of the genomics era. Expert opinion on drug discovery, 12(5), 475–487. https://doi.org/10.1080/17460441.2017.1303478
Zhang, M., Sala, C., Hartkoorn, R. C., Dhar, N., Mendoza-Losana, A., & Cole, S. T. (2012). Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. Antimicrobial agents and chemotherapy, 56(11), 5782–5789. https://doi.org/10.1128/AAC.01125-12
Zhang, W., Hong, D., Zhou, Y., Zhang, Y., Shen, Q., Li, J. Y., Hu, L. H., & Li, J. (2006). Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochimica et biophysica acta, 1760(10), 1505–1512.
https://doi.org/10.1016/j.bbagen.2006.05.009
Zhang, Z., & Tang, W. (2018). Drug metabolism in drug discovery and development. Acta pharmaceutica Sinica. B, 8(5), 721–732. https://doi.org/10.1016/j.apsb.2018.04.003
Zhao, H., & Akritopoulou-Zanze, I. (2010). When analoging is not enough: scaffold discovery in medicinal chemistry. Expert opinion on drug discovery, 5(2), 123–134. https://doi.org/10.1517/17460440903584874